NIVOLUMAB
Tracking # 20-810537
$99999.00
There are no ratings for this course
Learn more Educator STATPEARLS PUBLISHING, LLC
CE Broker Reporting Reported automatically
Method Computer-Based Training
Course overview
NIVOLUMAB IS A MEDICATION USED IN THE MANAGEMENT AND TREATMENT OF METASTATIC MELANOMA AND SEVERAL OTHER TUMORS. IT IS A MONOCLONAL ANTIBODY THAT TARGETS THE ANTI-PD1 RECEPTOR, AN IMMUNE CHECKPOINT. THIS ACTIVITY OUTLINES THE INDICATIONS, MECHANISM OF ACTION, AND ADMINISTRATION FOR NIVOLUMAB TO MANAGE ADVANCED CANCERS. THIS ACTIVITY WILL ALSO HIGHLIGHT THE DOSING, MONITORING, AND ADVERSE EVENT PROFILE, FACTOR OF PARAMOUNT IMPORTANCE FOR THE MULTIDISCIPLINARY HEALTHCARE TEAM IN TREATING PATIENTS WITH METASTATIC MELANOMA AND RELATED CONDITIONS.
Subject areas
This course counts toward the state boards and subject areas below.
Bahamas Medical Council
Specialty Medical Practitioner
1h
General Medicine
Louisiana State Board of Medical Examiners - Physicians & Surgeons
Physician & Surgeon
1h
Category I CME
Mississippi State Board of Medical Licensure
Medical Doctor
1h
AMA Category I
Physician Assistant
1h
AMA Category I
State Medical Board of Ohio
Doctor of Medicine
1h
AMA Category I